Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference

GAITHERSBURG, Md., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference.

Presentation details are as follows:

Date: Tuesday, September 26, 2017Time: 11:00 – 11:25 am ETLocation: Track 5, Montmartre, Sofitel Hotel, New York CityLive webcast: www.novavax.com, “Investors”/“Events”

A replay of the presentation will also be accessible under the “Investors/Events” section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:         

Investor RelationsNovavax, Inc.Andrea N. Flynn, Ph.D.Director, Investor & Media Relations[email protected]240-268-2000               Westwicke PartnersJohn Woolford[email protected]443-213-0506

MediaRusso Partners, LLCDavid SchullMaggie Beller[email protected] [email protected]212-845-4271  

You May Also Be Interested In

• NYC EATSS — Immersive Celebration of Native Culture, Food and Expression Returns to the Big Apple
• Queue Management System Market to Surpass USD 1455.08 Million by 2031, Propelled by Real-time Monitoring and Analytics
• FCA Packaging Invests in Greentree Packaging and Lumber